149 related articles for article (PubMed ID: 12422564)
1. [Reversible parkinsonism induced by prolonged treatment with valproate].
Barroso B
Therapie; 2002; 57(4):410-1. PubMed ID: 12422564
[No Abstract] [Full Text] [Related]
2. [Reversible Parkinsonism and cognitive impairment following treatment with valproate].
Toribio-Díaz ME; Morera-Guitart J; Palao-Duarte S
Rev Neurol; 2008 Oct 1-15; 47(7):390-1. PubMed ID: 18841554
[No Abstract] [Full Text] [Related]
3. Valproate-induced Parkinsonism in epilepsy patients.
Jamora D; Lim SH; Pan A; Tan L; Tan EK
Mov Disord; 2007 Jan; 22(1):130-3. PubMed ID: 17115396
[TBL] [Abstract][Full Text] [Related]
4. Valproate-induced parkinsonism: use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an "old" drug.
Hauben M; Reich L
Mov Disord; 2005 Mar; 20(3):387. PubMed ID: 15641014
[No Abstract] [Full Text] [Related]
5. Valproate-induced parkinsonism, glial cells and Alexander's disease.
Sechi GP; Conti M; Sau GF; Cocco GA
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1351-2. PubMed ID: 18495313
[No Abstract] [Full Text] [Related]
6. [Neuropsychiatric symptoms caused by valproic acid].
Andrade R; García-Espinosa A; Pérez-Montoto A; Toledo-Sotomayor G; Remón-González Y; Frades-García V
Rev Neurol; 2010 Jan 1-15; 50(1):62-3. PubMed ID: 20073028
[No Abstract] [Full Text] [Related]
7. [Parkinsonism induced by sodium valproate].
del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
[TBL] [Abstract][Full Text] [Related]
8. [Reversible dementia-like condition and parkinsonism in an elderly woman. Idiosyncratic adverse effects connected to 11 years of antiepileptic medication].
Lindbom U; Taubert B; Fahlqvist MS; Bergens A; Kimland E; Jonsson EW; Bergman U
Lakartidningen; 2009 Mar 18-24; 106(12):863-5. PubMed ID: 19452788
[No Abstract] [Full Text] [Related]
9. Diagnosis of Parkinsonism in older patients receiving sodium valproate.
Macphee GJ; Stewart DA
Mov Disord; 2007 Jun; 22(8):1211. PubMed ID: 17443705
[No Abstract] [Full Text] [Related]
10. Parkinsonism and/or cognitive impairment with valproic acid therapy: a report of ten cases.
Masmoudi K; Gras-Champel V; Masson H; Andréjak M
Pharmacopsychiatry; 2006 Jan; 39(1):9-12. PubMed ID: 16453247
[TBL] [Abstract][Full Text] [Related]
11. Movement disorders in patients taking anticonvulsants.
Zadikoff C; Munhoz RP; Asante AN; Politzer N; Wennberg R; Carlen P; Lang A
J Neurol Neurosurg Psychiatry; 2007 Feb; 78(2):147-51. PubMed ID: 17012337
[TBL] [Abstract][Full Text] [Related]
12. Valproate-induced rest tremor and parkinsonism.
Baizabal-Carvallo JF; Alonso-Juarez M
Acta Neurol Belg; 2021 Apr; 121(2):515-519. PubMed ID: 31721077
[TBL] [Abstract][Full Text] [Related]
13. A case of severe parkinsonism in an elderly person induced by valproic acid.
Tada H; Ogihara T; Nakamura T; Sasayama D; Sugiyama N; Takahashi Y; Washizuka S; Amano N
Psychogeriatrics; 2017 Jan; 17(1):76-77. PubMed ID: 26757408
[No Abstract] [Full Text] [Related]
14. Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature.
Mahmoud F; Tampi RR
Am J Geriatr Pharmacother; 2011 Dec; 9(6):405-12. PubMed ID: 21993183
[TBL] [Abstract][Full Text] [Related]
15. The frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy.
Ristić AJ; Vojvodić N; Janković S; Sindelić A; Sokić D
Epilepsia; 2006 Dec; 47(12):2183-5. PubMed ID: 17201721
[TBL] [Abstract][Full Text] [Related]
16. [Hyperammonemic encephalopathy associated with valproate acid].
Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
[TBL] [Abstract][Full Text] [Related]
17. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
Jaffe SL; Sanford M
Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
[No Abstract] [Full Text] [Related]
18. Reversible rapidly progressive dementia with parkinsonism induced by valproate in a patient with systemic lupus erythematosus.
Sleegers MJ; Beutler JJ; Hardon WJ; Berden JH; Verhave JC; Conemans JM; Hollander DA; Dautzenberg PL; Hoogeveen EK
J Am Geriatr Soc; 2010 Apr; 58(4):799-801. PubMed ID: 20398172
[No Abstract] [Full Text] [Related]
19. Valproate-induced parkinsonism in a demented elderly patient.
Iijima M
J Clin Psychiatry; 2002 Jan; 63(1):75. PubMed ID: 11838631
[No Abstract] [Full Text] [Related]
20. Acute hyperammonemic coma with chronic valproic acid therapy.
Cuturic M; Abramson RK
Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]